Chemists have long been drawn to radicals, the highly reactive fragments that form when a chemical bond breaks and leaves an atom or molecule carrying an unpaired electron. Because radicals eagerly seek out new bonds, they are powerful tools for assembling the intricate ring systems and carbon frameworks that underpin modern pharmaceuticals and other bioactive substances. Yet a persistent frustration has shadowed radical chemistry for decades: generating a radical efficiently is only half the battle. If the metal catalyst that produces the radical cannot promptly return to its original, active state, the entire reaction stalls, no matter how eagerly the radical wants to react. A research team at the Korea Advanced Institute of Science and Technology (KAIST) has now shown that the secret to unlocking difficult radical reactions lies not in pushing radical generation harder, but in carefully balancing that generation against the regeneration of the catalyst itself.
The study, led by Professor Sarah Yunmi Lee of KAIST’s Department of Chemistry and published online on August 3 in the Journal of the American Chemical Society, introduces a ligand-based strategy that tunes the redox behavior of a copper catalyst so that two competing steps of the catalytic cycle proceed in harmony. Ligands are molecules that bind to a metal catalyst and modulate its electronic properties, and the KAIST team turned to an unusual and comparatively underexplored class of them: cyclopropenimines, abbreviated CPI. By attaching a CPI-based ligand to copper, the researchers found they could regulate both how readily the catalyst generates radicals from challenging starting materials and how easily the catalyst is restored to its active form after each turnover. The result is a catalytic system that keeps working smoothly, cycle after cycle, under remarkably mild conditions.
To demonstrate the power of this approach, the team focused on a demanding class of starting materials known as tertiary alkyl halides, compounds in which a bromine or chlorine atom is attached to a tertiary carbon center. When the copper catalyst cleaves the carbon–halogen bond in these substrates, a highly reactive tertiary radical is born. In the reactions developed by the KAIST group, that radical then forms a new carbon–carbon bond with another reactive site within the same molecule, closing a ring in a process called radical cyclization. The transformation is conceptually simple, akin to tying the two loose ends of a string together to form a loop, but carrying it out efficiently with sluggish tertiary substrates has been a longstanding challenge in synthesis.
The crucial insight emerged when the researchers compared several different ligands on the same copper catalyst. Counterintuitively, ligands that were exceptionally good at generating radicals did not necessarily deliver more of the desired product. Some of the most aggressive radical-generating systems produced almost none of the target ring-closed compounds, because the catalyst became trapped in an inactive state and could not continue the cycle. In other words, a flood of radicals with no catalyst regeneration is a dead end. The analogy the team draws is a worker performing a task repeatedly: a catalyst that finishes one job and then cannot reset is useless, no matter how skillful it was at that single task. The CPI ligand acts as the helper that lets the worker move on to the next assignment without pausing after each one.
Redox chemistry sits at the heart of this balancing act. In copper-catalyzed radical reactions, the metal must typically accept an electron to cleave the carbon–halogen bond and generate the radical, and then release or regain electrons in subsequent steps to return to its resting, active oxidation state. If the ligand makes the copper too eager to accept electrons, radical generation is fast but the downstream steps that regenerate the catalyst lag behind, and the cycle jams. If the ligand makes the copper too sluggish, radicals form too slowly and the reaction crawls. The cyclopropenimine ligand occupies a sweet spot, tuning the oxidation-reduction properties of the copper center so that radical generation and catalyst regeneration are matched in rate, allowing each step of the cycle to hand off smoothly to the next.
With this balance achieved, the KAIST team succeeded in synthesizing 3,3-disubstituted oxindoles in high yields. Oxindoles are compounds built around a ring framework that appears repeatedly in medicinal chemistry, and the 3,3-disubstituted variants are structural motifs found in numerous pharmaceuticals and bioactive natural products. Constructing these quaternary carbon centers through radical cyclization of tertiary alkyl halides is exactly the kind of transformation that conventional methods have struggled to accomplish, which makes the new catalytic system a potentially valuable tool for medicinal chemists seeking efficient routes to complex, drug-like molecules.
Perhaps the most striking demonstration of the strategy’s power came from the behavior of the two halogens tested. Substrates bearing carbon–bromine bonds, which are relatively easy to break, reacted efficiently even at room temperature, a testament to how mild the overall conditions are. More impressively, the team also succeeded with substrates containing carbon–chlorine bonds, which are substantially stronger and far less willing to undergo activation. Tertiary alkyl chlorides have previously been difficult or impractical to use in radical cyclizations precisely because their bonds resist cleavage while their radicals, once formed, are so reactive that side reactions tend to dominate. The CPI-enabled copper catalyst overcame both obstacles, opening the door to a range of oxindole products that were previously difficult or impossible to access from chloride starting materials.
The broader lesson the authors draw from the work extends well beyond a single reaction class. Generating radicals well, they emphasize, is not sufficient on its own. Rather than simply maximizing the reactivity of one step in a catalytic cycle, catalyst designers should consider the entire cycle, including radical generation, bond-forming events, and catalyst regeneration, as an integrated system whose steps must remain in balance. This systems-level view suggests a general design principle for future radical-based catalytic reactions: instead of hunting for ever more reactive radical sources, chemists can achieve better outcomes by choosing ligands that harmonize the redox demands of every stage of the process. Such a principle could expand the range of challenging substrates available for chemical synthesis and guide the development of new reactions that were previously out of reach.
The practical implications are considerable. Milder reaction conditions mean less energy input, fewer protecting groups, and greater compatibility with sensitive functional groups, all of which matter when the goal is efficiently constructing complex molecules relevant to pharmaceuticals and other bioactive compounds. If the balancing principle generalizes, chemists may be able to recruit entire families of inexpensive, abundant alkyl chlorides as building blocks for drug discovery, substrates that have historically been sidelined in favor of their more reactive bromide and iodide counterparts. Professor Lee summarized the significance of the finding, stating that the study shows efficient radical generation alone is not sufficient and that the different processes within a catalytic cycle must proceed in balance. She added that the team expects the approach can be applied to the development of new radical-based catalytic reactions that make use of challenging substrates that have previously been difficult to activate.
Behind the publication stands a collaborative effort. Sarah Jang, a student in the integrated master’s–PhD program in KAIST’s Department of Chemistry, and Seongryeol Jeung, who earned a master’s degree at Yonsei University, served as co-first authors, with Sumin Kim, also an integrated master’s and PhD student in the Department of Chemistry at KAIST, participating as a third author. Professor Sarah Yunmi Lee is the corresponding author. The research was supported by the Samsung Science and Technology Foundation under Project SSTF-BA2202-06. As radical chemistry continues to expand its role in building the molecules of modern medicine, the KAIST team’s message is likely to resonate across the field: the fastest catalyst is not the one that generates radicals most aggressively, but the one that keeps every step of its cycle moving in step, turning the once-recalcitrant bonds of tertiary alkyl chlorides into reliable handles for molecular construction.
Subject of Research: Ligand-controlled redox balancing in copper-catalyzed radical cyclization of tertiary alkyl halides to synthesize 3,3-disubstituted oxindoles
Article Title: KAIST develops a strategy to balance radical generation and catalyst regeneration, enabling challenging chemical reactions
Article References: KAIST develops a strategy to balance radical generation and catalyst regeneration, enabling challenging chemical reactions. (n.d.). Original publication
Image Credits: AI Generated
DOI: Not provided
Keywords: copper catalysis, radical cyclization, cyclopropenimine ligand, redox control, tertiary alkyl chlorides, oxindoles, carbon-carbon bond formation, catalyst regeneration, KAIST, medicinal chemistry, homogeneous catalysis, alkyl halide activation
Cite Scienmag News
Bethany Barker. (September 20, 2026). Copper Catalyst Stays in Balance: KAIST Ligand Strategy Unlocks Stubborn Alkyl Chlorides for Drug-Like Molecules. Scienmag. https://scienmag.com/copper-catalyst-stays-in-balance-kaist-ligand-strategy-unlocks-stubborn-alkyl-chlorides-for-drug-like-molecules/
Bethany Barker. "Copper Catalyst Stays in Balance: KAIST Ligand Strategy Unlocks Stubborn Alkyl Chlorides for Drug-Like Molecules." Scienmag, 20 September 2026, https://scienmag.com/copper-catalyst-stays-in-balance-kaist-ligand-strategy-unlocks-stubborn-alkyl-chlorides-for-drug-like-molecules/. Accessed 20 September 2026.
Bethany Barker. "Copper Catalyst Stays in Balance: KAIST Ligand Strategy Unlocks Stubborn Alkyl Chlorides for Drug-Like Molecules." Scienmag. September 20, 2026. https://scienmag.com/copper-catalyst-stays-in-balance-kaist-ligand-strategy-unlocks-stubborn-alkyl-chlorides-for-drug-like-molecules/

